HALOZYME THERAPEUTICS INC·4

May 17, 4:29 PM ET

Frost Gregory Ian 4

4 · HALOZYME THERAPEUTICS INC · Filed May 17, 2012

Insider Transaction Report

Form 4
Period: 2012-05-15
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
  • Exercise/Conversion

    Common Stock

    2012-05-15+16,4653,553,331 total
Footnotes (1)
  • [F1]Represents net settlement of an award of 26,000 restricted stock units granted in May 2011. Upon vesting of this award on May 15, 2012, the reporting person received a settlement of 16,465 shares of Halozyme common stock. 9,535 shares were withheld as payment for minimum statutory tax withholding requirements.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT